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Abstract
Indium-tin oxide (ITO) is used to make transparent conductive coatings for touch-screen
and liquid crystal display electronics. As the demand for consumer electronics continues to
increase, so does the concern for occupational exposures to particles containing these po-
tentially toxic metal oxides. Indium-containing particles have been shown to be cytotoxic in
cultured cells and pro-inflammatory in pulmonary animal models. In humans, pulmonary al-
veolar proteinosis and fibrotic interstitial lung disease have been observed in ITO facility
workers. However, which ITO production materials may be the most toxic to workers and
how they initiate pulmonary inflammation remain poorly understood. Here we examined
four different particle samples collected from an ITO production facility for their ability to in-
duce pro-inflammatory responses in vitro. Tin oxide, sintered ITO (SITO), and ventilation
dust particles activated nuclear factor kappa B (NFκB) within 3 h of treatment. However,
only SITO induced robust cytokine production (IL-1β, IL-6, TNFα, and IL-8) within 24 h in
both RAW 264.7 mouse macrophages and BEAS-2B human bronchial epithelial cells. Our
lab and others have previously demonstrated SITO-induced cytotoxicity as well. These find-
ings suggest that SITO particles activate the NLRP3 inflammasome, which has been impli-
cated in several immune-mediated diseases via its ability to induce IL-1β release and cause
subsequent cell death. Inflammasome activation by SITO was confirmed, but it required the
presence of endotoxin. Further, a phagocytosis assay revealed that pre-uptake of SITO or
ventilation dust impaired proper macrophage phagocytosis of E. coli. Our results suggest
that adverse inflammatory responses to SITO particles by both macrophage and epithelial
cells may initiate and propagate indium lung disease. These findings will provide a better
understanding of the molecular mechanisms behind an emerging occupational
health issue.
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INTRODUCTION
Production of indium-tin oxide (ITO) involves mixing powdered indium oxide and tin oxide
in a 90:10 ratio (wt:wt), and then melding the materials into an ITO tile through a process
called sintering. This method uses high temperatures to create the final product; an ITO tile
that can be used to make “thin film” coatings [1, 2]. Recently, the demand for ITO has in-
creased as its incorporation into transparent conductive coatings for touch-screen phones, liq-
uid crystal displays (LCD), and solar panels makes it crucial in industries that
manufacture electronics.
The increased production of ITO has resulted in more workers being exposed to indium-
containing dusts, which has led to the recognition of a novel occupational condition, indium
lung disease. The first case of indium compound-related fatal lung disease was reported in a
worker that performed wet surface grinding of ITO, who developed interstitial pneumonia [3].
There were multiple indium- and tin-containing particles found in his lungs. Since then, other
studies have examined the relationship between serum indium levels and resulting lung disease
[4–7]. In terms of pulmonary symptoms and signs, workers exposed to ITO by inhalation de-
velop cough, dyspnea, and abnormalities on pulmonary function tests and chest computed to-
mography (CT) scans [3, 6, 7].
A recent comprehensive clinical and epidemiologic analysis of 10 reported cases, including
two from an ITO production facility in the United States, demonstrated that workers presented
with pulmonary alveolar proteinosis (within 6–14 months of hire) or fibrotic interstitial lung
disease with or without emphysema (within 2–14 years of hire) [8]. The current study and our
previous study [9] have utilized particles collected from this same US facility at various stages
in the ITO production process. These samples are in the micron size range and include various
starting materials, particles containing ITO, and dusts generated during the reclamation of in-
dium from leftover materials. Thus, we were able to expose cultured cells to the same particles
that workers may encounter throughout the ITO production process.
Previous laboratory studies of indium-containing particles have demonstrated toxicity in vitro
[9–11] and pulmonary inflammation in rodent models [10, 12–14]. However, how these particles
initiate inflammatory responses and induce cellular damage leading to pulmonary disease re-
mains unknown. Recent studies have implicated activation of the nod-like receptor protein 3
(NLRP3) inflammasome in the development of pulmonary fibrosis [15–17]. Inflammasome acti-
vation leads to the release of interleukin-1β (IL-1β), which unlike other cytokines requires not
only transcriptional activation, but also activation of the cysteine protease caspase-1 to induce
the processing and release of biologically active IL-1β. This cytoplasmic, multi-protein inflamma-
some complex is thought to play a role in the pathogenesis of several inflammatory diseases,
some of which are particle-induced. This is due to the fact that NLRP3 acts as a sensor for a varie-
ty of different “danger” signals. For example, it can be triggered by endogenous particles, such as
cholesterol crystals [18], monosodium urate [19] and fibrillar amyloid β [20], along with exoge-
nous particles, such as crystalline silica [21, 22] and asbestos [23].
A main goal of this study was to determine whether a particular stage or process of ITO pro-
duction puts workers at higher risk for developing indium lung disease, based on adverse cellu-
lar reactions to collected ITO production particles. Our group previously revealed sintered ITO
(SITO) particles to be cytotoxic in cultured cells, but the mechanism behind this toxicity re-
mains to be elucidated. Here we sought to determine whether cultured cells react to the parti-
cles in a pro-inflammatory manner and whether particle uptake affects cellular functions such
as phagocytosis. Our findings suggest that particle uptake and subsequent pro-inflammatory
responses may be responsible for the initiation and/or pathogenesis of pulmonary diseases that
occur in indium-exposed workers.
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MATERIALS ANDMETHODS
ITO production particles and reagents
The particles used in this study were collected at a United States ITO production facility from
containers of feedstock materials or production processes [24]. Tin oxide (SnO2), unsintered
ITO (UITO), and sintered ITO (SITO) are from the ITO department; and ventilation dust
(VD) is from the reclamation department. The particles were extensively characterized in a
previous study by our group [9]. The SnO2 is crystallographically pure and the other 3 samples
are compound mixtures containing oxygen, carbon, indium, and tin. UITO is 46% O, 29% C,
22% In, and 2.8% Sn (atom % at particle surface by X-ray photoelectron spectroscopy). SITO is
44% O, 19% C, 24% In, and 2.7% Sn. VD is 21% O, 49% C, 12% In, and 0% Sn. The SITO parti-
cles were collected in the grinding area and had been in contact with metalworking fluid. The
particles were suspended in sterile filtered 1X phosphate-buffered saline (PBS), vortexed, and
diluted into cell culture media at a final concentration of 50 μg/ml by total weight. The dose
was based on a previous cytotoxicity study of these particles by our group [9]. Stock suspen-
sions of particles were prepared fresh for experiments and equal volumes of 1X PBS were used
as control conditions. Crystalline silica (Min-U-sil, 5 μm) was used as a control particle in
some experiments, due to its ability to activate the NLRP3 inflammasome [21–23, 25] and due
its micron-range size, which is similar to the size of the ITO particles. Lipopolysaccharide from
E. coli serotype 055:B5 (LPS) and Cytochalasin D were purchased from Sigma-Aldrich
(St. Louis, MO). Glybenclamide and Z-YVAD-FMK were purchased from InvivoGen (San
Diego, CA).
Endotoxin analysis of particle samples
Because metalworking fluid is commonly contaminated with gram negative bacteria [26], and
endotoxin is a potent immune stimulant, we examined the endotoxin content of SITO parti-
cles. Endotoxin potency of particle samples was determined using kinetic chromogenic Limu-
lus amoebocyte lysate (LAL: Associates of Cape Cod, Inc., Falmouth, MA) assay. All glassware
used was baked at 260° C for 2–2.5 h to render them endotoxin-free. Prior to the assay, 20 mg
of particle sample or 1 ml of metal working fluid sample were extracted in TAP (triethylamine
phosphate) buffer or LRW (LAL reagent water) with 0.005% Tween 20, respectively. The sam-
ple in extraction solution was sonicated for 1 h using an ultrasonic water bath sonicator (Bran-
sonic Model 5510, Branson Ultrasonics Corp., Danbury CT) with vortexing every 15 min. All
the sample extracts and control standard endotoxin (lot #134, Associates of Cape Cod, Inc.,
Falmouth, MA) were serially diluted in LAL reagent water, and 50 μl aliquot of each of the seri-
al dilutions were added to a 96 well plate in duplicates. Then 50 μl of lysate reconstituted with
Glucashield buffer (Associates of Cape Cod, Inc.) to block interference of (1!3)-ƅ-D-glucan
was added to the standard, sample, and negative control (LRW and Glucashield buffer) wells.
Immediately after the lysate was added, the plate was placed in a microplate reader (ELx808IU,
BioTek Instruments, Inc., Winooski, VT) and optical density in each well at 405 nm was re-
corded every 30 s for 120 min. SITO particles were baked at 270° C and then retested to con-
firm a lack of endotoxin activity. With the kinetic data, endotoxin potency was estimated using
onset time and a parallel-line estimation method [27]. The potency was reported in endotoxin
unit (EU) relative to reference standard endotoxin (lot # G3E069; E. coli O113:H10 strain).
Cell culture
The adherent mouse monocyte-derived macrophage cell line, RAW 264.7 (RAW), and the
human bronchial epithelial cell line, BEAS-2B, were obtained from ATCC (Manassas, VA).
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RAW cells were selected for these studies because of their potential to react with and engulf
particles [11, 28]. The inclusion of BEAS-2B bronchial epithelial cells in these analyses is due to
the potential role of the lung epithelium in indium lung disease. Both cell lines were grown and
passaged as previously described [9].
Transmission electron microscopy
RAW and BEAS-2B cells were grown to about 70% confluency in 6 well dishes and treated
with particle suspensions for 3 h. Following treatments, cells were washed twice with 1X PBS,
scraped (RAW) or trypsinized (BEAS-2B), and centrifuged to pellet the cells. The samples were
fixed in Karnovsky’s (2.5% gluteraldehyde, 2.5% paraformaldehyde in 0.1M Sodium Cacodylic
buffer) fixative, post-fixed in osmium tetroxide, mordanted in 1% tannic acid and stained en
bloc in 0.5% uranyl acetate. The pellets were embedded in epon, sectioned and stained with
Reynold’s lead citrate and uranyl acetate. The sections were imaged on a JEOL 1220 transmis-
sion electron microscope (JEOL USA, Inc., Peabody, MA) at 10,000 times magnification using
a 5 kV accelerating voltage.
Phagocytosis assay
RAW cells were plated at 1 x 105 cells/well in 96 well dishes and treated with particle suspen-
sions for 3, 6, or 12 h. The pHrodo Red E. coli BioParticles were prepared according to manu-
facturer’s instructions (Molecular Probes, Carlsbad, CA), and the assay was carried out as
previously described [29]. Briefly, at each time point, wells were washed and BioParticle sus-
pensions were added to all wells, including blanks (no cells) to be subtracted from all experi-
mental wells. Following incubation for 2 h at 37° C, plates were read at 560 nm excitation/600
nm emission to measure changes in fluorescence. Cytochalasin D at a final concentration of
10 μMwas used as a positive control in certain wells to inhibit phagocytosis. All conditions
were run in triplicate wells and at least three independent experiments were performed. The
percentage of maximal phagocytosis was calculated as a ratio of the net experimental phagocy-
tosis to the PBS control phagocytosis.
The assay above was also carried out with RAW cells on coverslips in 12 well dishes. Howev-
er, rather than measuring fluorescence as a final step, the coverslips were washed twice, fixed
for 10 min in formaldehyde, and mounted onto ultra clean glass slides (Schott Nexterion, Ar-
lington, VA) with Fluoromount G. Conditions were performed in duplicate, and dual-mode
images of cells with particles and E. coli were acquired using a CytoViva enhanced darkfield
microscopy system (Aetos Technologies, Inc., Auburn, AL) integrated into an Olympus BX41
upright microscope equipped with an Olympus DP73 digital camera (Olympus, Center Valley,
PA) to attain images of high-contrast particles (bright spots) against a dark background.
Western blotting
RAW and BEAS-2B cells were grown to about 70% confluency in 6 well dishes and treated
with particle suspension for 1 or 3 h. Cells were washed twice with 1X PBS, lysed with RIPA
buffer (Thermo Scientific, Rockford, IL), and incubated on ice for 10 min prior to spinning for
15 min at 3000 x g. A BCA protein assay (Thermo Scientific) was used to determine protein
concentration in each lysate sample, and lysates were boiled for 5 min with 5X laemmli sample
buffer. SDS-PAGE was performed on prepared lysate samples, and proteins were transferred to
PVDF membranes, and probed with antibodies against IκBα (1:1000; cat. no. sc-371, Santa
Cruz Biotechnology, Santa Cruz, CA), stripped and re-probed for β-actin (1:8,000; cat. no.
MA191399, Fisher Scientific, Pittsburgh, PA). Lysates from four independent experiments
were run for each condition. Chemiluminescence detection and densitometry analysis were
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used to determine relative IκBα levels, normalized to actin loading controls, and then com-
pared to PBS controls.
Immunocytochemistry
When cells were plated for the western blot experiments, coverslips were first added to the cul-
ture dishes, so that a portion of the treated cells could also be fixed and examined for p65 nu-
clear translocation. Prior to the addition of RIPA buffer, coverslips were removed from wells
and fixed for 10 min with methanol/acetone (1:1 vol:vol) at -20° C. Cells were washed twice
with 1X PBS, and immunofluorescence was carried out using primary antibodies against NFκB
subunit p65 (1:200; cat. no. PA1-14298, Thermo Scientific) and secondary Alexa 488 antibody
conjugates (1:200; Invitrogen, Grand Island, NY). Coverslips were mounted onto slides with
Fluoromount G, and cells were imaged using an Olympus AX70 microscope equipped with an
Olympus DP73 digital camera (Olympus, Center Valley, PA).
Enzyme-linked immunosorbent assay (ELISA)
3 x 105 RAW cells/well and 1 x 105 BEAS-2B cells/well were plated in 12 well dishes and were
treated with particle suspensions for 24 h. LPS at 1 μg/ml was used as a positive control for cy-
tokine production or was used to prime RAW cells for 3 h prior to particle suspension treat-
ments (for IL-1β repeat measurements only). Media were collected from wells and frozen at
-80° C. Cytokine levels were measured via BD OptEIA ELISA kits (mouse IL-6; cat. no. 555240,
mouse IL-1β; cat. no. 559603, mouse TNFα; cat. no. 555268, human IL-6; cat. no. 555220,
human IL-8; cat. no. 555244, BD Biosciences, San Diego, CA) according to manufacturer’s di-
rections, except for a few changes following kit optimizations. For IL-1β, the protocol was mod-
ified such that secondary antibodies were diluted at 1:250. For the human IL-6 and IL-8 kits,
primary and secondary antibodies were diluted at 1:500 and 1:1000, respectively. All conditions
were run in duplicate wells and at least three to four independent experiments were performed.
Inflammasome inhibition assays
RAW cells were plated, treated, and assayed as in the ELISA assay above, but cells were first
pre-treated with either 200 μM of the ATP-sensitive K+ pump inhibitor Glybenclamide or
40 μM of the caspase-1 inhibitor Z-YVAD-FMK for 1 h prior to particle suspension treat-
ments. Wells receiving Min-U-sil were used as a positive control for in vitro inflammasome ac-
tivation. All conditions were run in duplicate wells and four independent experiments
were performed.
Caspase-1 activation
RAW cells were plated at 5 x 105 cells/well in 6 well dishes, treated with SITO, LPS alone, or
Min-U-sil (cells were first primed with LPS). Cells were washed, lysed, and 100 μg of lysates
were assayed for their ability to cleave a fluorescent caspase-1 substrate, YVAD-AFC according
to the manufacturer’s protocol (cat. no. ab39412, Abcam, Cambridge, MA). Values were nor-
malized to PBS controls. All conditions were run in duplicate wells and three independent ex-
periments were performed for each time point.
Cytotoxicity Assay
RAW cells were plated at 2.5 x 104 cells/well and BEAS-2B cells were plated at 5 x 103 cells/well
in 96 well dishes, followed by treatments with SITO, baked SITO, LPS, or Min-U-sil (after 3 h
priming with LPS). Changes in cell viability at 24 and 48 h were assessed using the MultiTox-
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Fluor Cytotoxicity Assay according to the manufacturer’s directions (Promega, Madison, WI).
A cell-permeable protease substrate, GF-AFC (glycyl-phenylalanyl-amino-fluorocoumerin), is
cleaved by live cells to produce fluorescent AFC. Thus, the fluorescent signal is proportional to
the number of viable cells. To ensure the fluorescent signal was due to substrate products and
not autofluorescence or interference by the particles, separate wells of medium and particle sus-
pensions were included in the plates, and these readings were subtracted from their respective
wells that contained treated cells. Values were normalized to PBS controls. All conditions were
run in triplicate wells and four independent experiments were performed.
Statistical analysis
All data are represented as the mean ± standard deviation (SD) for each condition. One-way
and two-way analysis of variance tests with Tukey or Dunnett’s post-tests were performed
using GraphPad Prism 6 software (GraphPad Software, Inc., La Jolla, CA) for each experiment
to compare the responses between groups, and statistical significance is shown when p< 0.05.
RESULTS
Process description and particle characteristics
The particles used in this study were collected from different areas of an ITO facility and repre-
sent various stages of the production process. Tin oxide (SnO2) is one of the starting materials
used to manufacture ITO and contains no indium. Unsintered ITO (UITO) is a mixture of
SnO2 and indium oxide (In2O3), which, after firing, becomes sintered ITO (SITO). The SITO
particles were generated during wet grinding of the final product to customer specifications.
The ventilation dust (VD) was collected from the ventilation system within the reclaim depart-
ment of the facility, where indium is recycled from leftover materials. These particles were fully
characterized in a previous study by our group, and were found to have mean aerodynamic di-
ameters in the range of 0.5 to 1.2 μm [9]. Thus, these represent respirable particles in the mi-
cron size range. Varying amounts of indium were found on the particle surfaces via XPS
elemental analysis with a sampling depth of about 10 nm (SnO2, 0%; UITO, 22%; SITO, 24%;
VD, 12% indium). This study also revealed SITO to be the only particle type that was cytotoxic
at the low dose of 50 μg/ml in both RAW and BEAS-2B cells within 48 h [9]. Thus, particle sus-
pensions at this concentration were used for all experiments.
Post-sintered ITO tiles are sprayed with metalworking fluid that is used during cutting and
grinding as a coolant, and in industrial settings metalworking fluids commonly become colo-
nized by gram negative bacteria [26]. Results from a Limulus amoebocyte lysate (LAL) assay re-
vealed that the SITO particles indeed contained endotoxin at 51.66 EU/mg, while the other
samples contained negligible activity (Table 1). Given that 1 EU (endotoxin unit) per ml is esti-
mated to represent 0.1 ng LPS per EU, and the SITO particle suspensions were diluted to a







*baked for 1 h at 270° C.
doi:10.1371/journal.pone.0124368.t001
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final concentration of 50 μg/ml for cell treatments, this equates to approximately 0.26 ng/ml
LPS or 2.58 EU/ml. The source of the endotoxin was confirmed to be the metalworking fluids
used on the ITO tiles post-sintering (via LAL assay on fluid samples from all 11 grinder ma-
chines). Thus, workers operating grinders could be exposed to aerosolized, endotoxin-contain-
ing SITO particles as opposed to contaminant-free SITO. We therefore explored the possible
role of endotoxin in the toxicity of these particles, as they represent a real-life worker exposure.
Particle uptake by cells and phagocytosis impairment
Transmission electron microscopy (TEM) revealed that both RAW and BEAS-2B cells en-
gulfed the particles within 3 h of exposure (Fig 1). Although not quantitative, the images of
VD-treated cells appeared to have less particle uptake compared to the other three samples.
We hypothesized that pre-uptake of the particles would impair the ability of macrophages to
properly phagocytose pathogens. Therefore, an assay was employed using pH-sensitive E. coli
particles that fluoresce upon proper phagocytosis. Fig 2 demonstrates that when RAW cells
were exposed to SITO or VD, maximal phagocytosis of subsequently added E. coli particles was
significantly impaired. The effect with VD occurred more rapidly, with impairment beginning
at 3 h pre-treatment, while SITO-induced reductions were first observed with a 6 h pre-treat-
ment. Images of treated cells agree with the assay findings, in which the red fluorescence signal
was drastically weaker with SITO and VD treatments (Fig 2B), indicating fewer E. coli particles
were properly phagocytosed by cells that had taken up those particles.
Fig 1. Transmission electronmicrographs of cells treated with ITO production particles.
Representative images of A. RAW andB. BEAS-2B cells after 3 h exposures to particle suspensions at
50 μg/ml. Images were acquired at 10,000 times magnification using a 5 kV accelerating voltage. Insets show
magnified engulfed particles. Scale bars, 2 μm or 500 nm.
doi:10.1371/journal.pone.0124368.g001
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NFκB activation following ITO production particle exposures
Given the pulmonary inflammatory response seen in animals treated with various indium-con-
taining particles [10, 12–14], we suspected pro-inflammatory signaling pathways may be acti-
vated in cultured cells treated with ITO production particles. Thus, activation of nuclear factor
kappa B (NFκB) was examined via degradation of the inhibitory protein IκBα in RAW and
BEAS-2B cells. Western blotting densitometry revealed that SnO2, SITO, and VD caused sig-
nificant IκBα protein level reductions at 3 h post-treatment in RAW cells (Fig 3A). Both SITO
and VD also induced IκBα degradation in BEAS-2B cells (Fig 3D), suggesting that the particle-
induced NFκB activation may not be cell type-specific. Immunocytochemistry, using antibod-
ies against the NFκB transcription factor p65, was used to confirm nuclear accumulation of
this protein following IκBα degradation. The same particles that induced IκBα degradation
also had pronounced overlay of p65 with the DAPI nuclear stain in cells (Fig 4).
Fig 2. Pre-uptake of SITO or VD impairs phagocytosis. A. RAW cells were treated with particle
suspensions for 3, 6, or 12 h or Cytochalasin D (Cyto D) 3 h. Cells were washed, pHrodo Red E. coli
BioParticles were added for 2 h, then plates were read to measure changes in fluorescence. Error bars
represent the mean ± SD (n = 4 for 3 h and 6 h, n = 3 for 12 h). *, p < 0.05 compared to PBS. B. The same as
inA, except cells were exposed to particle suspensions for 6 h on coverslips, fixed with formaldehyde
following E. coli particle incubations, and mounted onto slides. Images were acquired at 60x magnification
using dual-mode fluorescence and enhanced darkfield microscopy to show phagocytosed E. coli (red) and
cell-associated particles (bright spots). Scale bar, 10 μm.
doi:10.1371/journal.pone.0124368.g002
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Cytokine production in response to ITO production particles
To further explore the influence of the particles on pro-inflammatory activation, various cyto-
kines (IL-6, TNFα, and IL-1β from RAW cells and IL-6 and IL-8 from BEAS-2B cells) were
measured from the culture media of cells treated for 24 h with the particle suspensions. Al-
though SnO2, SITO, and VD induced NFκB activation, only SITO induced significant cytokine
production in both cell lines (Fig 5). In BEAS-2B cells, SnO2 caused significant IL-6 production
as well. It was not surprising that SITO was pro-inflammatory in both cell lines, given the pres-
ence of endotoxin (LPS) in this sample (Table 1).
Inflammasome activation by SITO
The release of biologically active IL-1β from cells in vitro requires activation of the NLRP3
inflammasome [30]. Studies of other extracellular particles, such as cholesterol crystals [18], as-
bestos [23], monosodium urate [19], and crystalline silica [21, 22] report the need to first
prime macrophages with LPS in order to induce IL-1β production and release. Since SITO con-
tains low levels of LPS and induced significant IL-1β release from unprimed RAW cells,
Fig 3. ITO production particles cause IκBα degradation. Representative western blot images of IκBα and actin from treated RAW (A) and BEAS-2B (C)
cell lysates. Cells were treated with particle suspensions for 1 or 3 h, washed twice with PBS, and lysed.B, D. Densitometry analysis was performed and is
represented as the percentage of IκBα compared to levels present in PBS control-treated lysates. Error bars represent the mean ± SD (n = 4). *, p < 0.05
compared to PBS.
doi:10.1371/journal.pone.0124368.g003
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inflammasome activation was investigated. To confirm that components of the NLRP3 inflam-
masome were involved in this response, inhibitors were added to RAW cells prior to treatment
with SITO. Glybenclamide blocks ATP-sensitive K+ pumps [31], while the inhibitory substrate
Z-YVAD-FMK blocks caspase-1 activity. LPS priming followed by Min-U-sil treatment was
used as a positive control for inflammasome activation and at a higher concentration than
Fig 4. Nuclear accumulation of p65 following particle exposures.RAW (A) and BEAS-2B (B) cells were
grown on coverslips and treated with particle suspensions for 3 h as in Fig 3. Prior to adding lysis buffer to
wells, coverslips were removed, fixed, and stained with antibodies against NFκB subunit p65. Coverslips
were mounted onto slides with Fluoromount G (DAPI) and sealed with nail polish. Experiments were
performed in duplicate, and cells were imaged at 40x. Scale bar, 20 μm.
doi:10.1371/journal.pone.0124368.g004
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SITO (150 μg/ml vs. 50 μg/ml), based on concentrations used in previous studies to induce IL-
1β release [21, 23, 25]. Pre-treatment of cells with either inhibitor led to significantly reduced
levels of IL-1β in the culture media following a 24 h exposure of both SITO and Min-U-sil (Fig
6A). This suggests that SITO-induced IL-1β production requires K+ efflux and caspase-1 activi-
ty, which have been shown to be essential for inflammasome activation and IL-1β release [32–
34].
Fig 5. Pro-inflammatory cytokine production with particle exposures. Cells were treated with particle suspensions or 1 μg/ml of LPS as a positive
control for 24 h. Media were collected, and ELISAs were run to measure levels of IL-6, TNFα, and IL-1β from RAW cells (A) or IL-6 and IL-8 from BEAS-2B
cells (B). Error bars represent the mean ± SD (n = 4). *, p < 0.05 compared to PBS.
doi:10.1371/journal.pone.0124368.g005
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Fig 6. Inflammasome activation in RAW cells by SITO particles. A. RAW cells were pre-treated with
either 40 μM Z-YVAD-FMK (caspase-1 inhibitor) or 200 μMGlybenclamide for 1 h. Cells were then treated for
24 h with SITO (50 μg/ml), LPS alone (1 μg/ml), or Min-U-sil following LPS priming (LPS + Si; 150 μg/ml).
Media were collected and ELISAs were run to measure levels of IL-1β (n = 4). *, p < 0.05 compared to no
inhibitor conditions.B. Cells were treated as in A (without inhibitors) for the time points listed, lysed, and
100 μg lysates were assayed for caspase-1 activity. Values were normalized to PBS controls. *, p < 0.05
compared to PBS at that time point.C.Media collected from (B) were measured for IL-1β at the 12 h time
point (n = 3). Error bars represent the mean ± SD (n = 3). *, p < 0.05 compared to PBS.
doi:10.1371/journal.pone.0124368.g006
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To further confirm the ability of SITO particles to induce inflammasome activation, treated
cell lysates were measured for caspase-1 activation. After 12 and 24 h exposures to SITO,
caspase-1 activation was significantly enhanced in cells when normalized to PBS controls
(151.9% ± 10.2% at 12 h and 143.2% ± 8.9% at 24 h, mean ± SD) (Fig 6B). In Fig 5, IL-1β levels
had only been measured as early as 24 h, so an ELISA was run on the 12 h media to determine
whether caspase-1 activation by SITO led to IL-1β release by the 12 h time-point. However, as
shown in Fig 6C, IL-1β was only significant for Min-U-sil treatment by 12 h, which caused
caspase-1 activation at earlier times than SITO. Therefore, caspase-1 activation preceded
IL-1β release.
Inflammasome activation by ITO production particles in LPS-primed
cells
As previously stated, the SITO particles collected in the workplace were contaminated with en-
dotoxin. The presence of endotoxin accounts for the robust inflammasome activation observed,
but we wanted to determine if endotoxin-free SITO particles could induce IL-1β release using
the well-established method of priming macrophages with LPS prior to particle treatment. Bak-
ing SITO particles for 1 h at 270° C removed endotoxin activity (Table 1), and these “baked
SITO” particles were used for further investigation. Given that these particles were generated
post-sintering, which utilizes very high temperatures (>1000° C), baking them at 270° C is not
expected to alter the physical or chemical characteristics. The other 3 particle samples, al-
though not present with LPS in the workplace environment, could potentially activate the
inflammasome in LPS-primed cells. Thus, all 4 particle samples (SnO2, UITO, baked SITO,
and VD) were tested for their ability to induce IL-1β production in primed RAW cells. The re-
sults in Fig 7 demonstrate that baked SITO and VD caused significant IL-1β production over
LPS priming alone. Therefore, even without endotoxin contamination from the workplace,
SITO was confirmed to be an inflammasome activator. VD was also shown to be an activator
under these conditions. Given that VD particles were generated during indium recycling of
leftover ITO materials, the VD particles may contain SITO.
Fig 7. Particle-induced inflammasome activation in LPS-primed cells.RAW cells were primed with LPS
for 3 h, followed by particle treatments for 24 h. Media were collected, and ELISAs were run to measure levels
of IL-1β. Error bars represent the mean ± SD (n = 4). *, p < 0.05 compared to LPS priming alone.
doi:10.1371/journal.pone.0124368.g007
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Baked SITO inflammatory effects on cells
To further evaluate the adverse cellular effects of SITO exposure in the absence of endotoxin,
cytokine release was re-measured with baked SITO, as shown in Fig 8. Baked SITO did not in-
duce cytokine production from exposed (unprimed) RAW cells, indicating that the presence of
endotoxin in the original SITO was necessary for the pro-inflammatory cytokine release in Fig
5A. However, the BEAS-2B cell results indicate that SITO particles caused significant
Fig 8. Cytokine production from baked SITO exposures.Cells were treated with SITO, baked SITO, or LPS for 24 h as in Fig 5. Media were collected,
and ELISAs were run to measure levels of IL-6, TNFα, and IL-1β from RAW cells (A) or IL-6 and IL-8 from BEAS-2B cells (B). Error bars represent the
mean ± SD (n = 4). *, p < 0.05 compared to PBS.
doi:10.1371/journal.pone.0124368.g008
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production of IL-6 and IL-8 in the absence of endotoxin (Fig 8B). Therefore, the ability of
baked SITO to induce pro-inflammatory responses in vitro appears to be cell type-specific.
Baked SITO still impaired phagocytosis by RAW cells, but the baking delayed the onset of
this deficiency. As shown in Fig 9, the original, unbaked SITO exposure for 6 h led to signifi-
cantly impaired phagocytosis of E. coli particles. However, when carried out with baked SITO,
significant impairment was observed at 12 h. Thus, pathogen phagocytosis was still negatively
impacted with endotoxin-free SITO exposure.
Endotoxin-free SITO cytotoxicity
A previous study by our laboratory showed the same SITO particles to be cytotoxic in both cell
lines at 50 μg/ml [9]. However, it is possible that the presence of endotoxin contributed signifi-
cantly to the cell viability loss measured. Therefore, a cytotoxicity assay was performed to mea-
sure the activity of a protease that is only active in viable cells. Compared to PBS controls, there
were significant reductions in the live cell signal for both cell lines with baked SITO treatments
(Fig 10). In RAW cells, the presence of endotoxin caused unbaked SITO to be significantly
more toxic than baked SITO, but LPS was shown to be toxic as well in these cells (Fig 10A).
This effect was not observed in BEAS-2B cells, as baked and unbaked SITO were equally toxic
(Fig 10B). Regardless, the inactivation of endotoxin did not prevent cytotoxicity of SITO in ei-
ther cell line, and therefore, SITO particles themselves were toxic to multiple cell types.
DISCUSSION
The use of metal oxides in manufacturing has long been a concern for the occupational safety
of exposed workers. With the boom of the consumer electronics industry in the United States
and abroad, there has been a steady increase in the use of various metal-containing com-
pounds. Indium-tin oxide represents one of the emerging materials being incorporated into
many electronics and has been hazardous to workers in the ITO industry [5, 8, 35]. The present
study aimed to evaluate the pro-inflammatory effects of particles collected from an ITO facility
on cultured cells to uncover the molecular mechanisms of indium lung disease and determine
if certain stages of ITO processing pose a higher risk for workers.
Recent studies have demonstrated inflammatory responses in the lungs of ITO-treated ro-
dents [10, 12–14]. Thus, our findings that various indium-containing particles were capable of
inducing cytokine production and macrophage dysfunction in vitro were consistent with prior
Fig 9. Baked SITO pre-treatment impairs phagocytosis. The phagocytosis assay was carried out as in Fig
2, but with baked SITO for comparison. Error bars represent the mean ± SD (n = 3). *, p < 0.05 compared to
PBS at that time point.
doi:10.1371/journal.pone.0124368.g009
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studies. In humans, it is hypothesized that indium lung toxicity can lead to macrophage dys-
function, resulting in the excessive accumulation of alveolar surfactant proteins [8]. This has
been seen in workers from the ITO industry that present with pulmonary alveolar proteinosis
[8, 36] and in rodents exposed to ITO via inhalation [12, 13]. Therefore, macrophage dysfunc-
tion due to ITO particle uptake may be an initiating factor in pulmonary alveolar proteinosis
in those workers. The results appear to be specific to particles that contain SITO (including VD
from the reclaim department, where production waste and used SITO tiles are broken down)
and not simply due to particle overload, as pre-uptake of SnO2 or UITO particles at the same
concentration did not impair phagocytosis by RAW cells. Also, studies of other metal oxide-
containing particles, such as steel-based welding fume particulates, did not impair RAW
phagocytosis of E. coli [29], which further validates our interpretation of the results. It is inter-
esting that VD appeared to be taken up the least by cells, and yet it impaired E. coli phagocyto-
sis the most rapidly (Figs 1 and 2). Whether impaired phagocytosis has clinical implications in
terms of increased susceptibility of workers to pulmonary infections is not known, but may
warrant further investigation.
Fig 10. Baked SITO cytotoxicity in RAW and BEAS-2B cells. Treatments with SITO, baked SITO, LPS
alone, or Min-U-sil (Si) were carried out for 24 and 48 h in RAW (A) and BEAS-2B (B) cells. MultiTox-Fluor
Reagent (Promega) was added to all wells for 1 h at 37° C, and plates were read at 400ex/505em to
determine the fluorescence signal from live cells. Values were normalized to PBS controls. Error bars
represent the mean ± SD (n = 4). *, p < 0.05 compared to PBS.
doi:10.1371/journal.pone.0124368.g010
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The examination of endpoints such as NFκB activation and cytokine release demonstrated
that SITO was pro-inflammatory in both RAW and BEAS-2B cells. The robust release of IL-6,
TNFα, and IL-1β by RAW cells treated with SITO suggested that toll-like receptor (TLR) and
NFκB signaling may be occurring to induce “classical”macrophage activation. Release of IL-6
and IL-8 from BEAS-2B cells confirmed that this was not a cell type-specific response. Further,
SITO was capable of inducing inflammasome activation and subsequent IL-1β release in
unprimed macrophages. In similar studies, priming with LPS always preceded particle or ATP
treatments to induce NLRP3 activation and IL-1β release [22, 23, 25, 37–40]. The cause of
these pro-inflammatory findings was clearly due to endotoxin activity in the SITO particles. At
first this finding was perplexing, as the process of sintering would inactivate any endotoxin
present, due to the very high temperatures used. After consulting with an industrial hygienist
who visited this specific ITO facility, we learned that post-sintered ITO tiles are sprayed with
metalworking fluid during cutting and grinding as a coolant. As suspected, endotoxin activity
was found in all of the metalworking fluids collected from the ITO department where these
SITO particles were generated.
A strong advantage of this study is the utilization of particle samples that workers handle;
thereby representing real-life exposures. Thus, the endotoxin-contaminated particles are still
very much occupationally relevant, as these airborne dusts are what workers could be exposed
to, as opposed to contaminant-free ITO purchased from a chemical supplier. If the SITO prod-
uct was exposed to fluids containing endotoxin, those workers handling it (i.e., grinders) would
be exposed not only to the airborne dusts, but also to endotoxin. In light of our findings regard-
ing the synergistic effects of endotoxin, it is notable that half of the 10 clinical cases of indium
lung disease reported in the medical literature as of 2010 occurred in ITO grinders, who would
have the highest risk of a combined SITO-endotoxin exposure [8].
In addition, the fact that SITO required the presence of a TLR agonist (endotoxin contami-
nation or LPS-priming) for significant IL-1β production agrees with all other studies of parti-
cle-induced NLRP3 inflammasome in macrophage cells, as referenced above. Activators of the
inflammasome include a diverse variety of endogenous and exogenous particulates, and other
occupational particles have been shown to induce the inflammasome as well [41]. This activa-
tion and subsequent pro-inflammatory cytokine release is thought to underlie progression of
the particle-related diseases. For example, there have been several studies suggesting that silica-
and asbestos-induced inflammasome activation in macrophages contribute to silicosis and as-
bestosis, respectively [22, 23, 25]. Similar to asbestos, various carbon nanotubes have also re-
cently been shown to be NLRP3 agonists in LPS-primed human primary macrophages [42,
43]. Given that SITO and Min-U-sil induced similar levels of IL-1β release (Fig 6) and cell
death (Fig 10) when the concentration of SITO was one-third that of Min-U-sil (50 vs. 150 μg/
ml), SITO may be more potent than silica at initiating inflammatory lung injury in vivo. Al-
though no other studies of indium-containing particle inflammasome activation exist in the lit-
erature, other metal particles have demonstrated the ability to activate the inflammasome.
Caicedo et al. [44] found IL-1β production by human THP-1 macrophage cells exposed to
Chromium, Cobalt, and Nickel metal ions.
Of course, it is of value to the field of toxicology and molecular biology to analyze the cyto-
toxicity and adverse responses of cells to this particle type without the influence of LPS. There-
fore, assays were repeated with baked, endotoxin-free SITO. The contribution of the particle
itself to cytokine release in BEAS-2B cells was significant, as baked SITO still induced IL-6 and
IL-8 when ELISA assays were repeated (Fig 8B). The endotoxin-free particles were no longer
pro-inflammatory in RAW cells; however, they still induced significant IL-1β release when
cells were first primed with LPS. Baked SITO also impaired proper E. coli phagocytosis, but
with a delayed response compared to unbaked SITO. Thus, in macrophage cells, endotoxin-
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free SITO particle exposure caused phagocytic dysfunction but did not induce cytokine release,
while the exposure still led to a pro-inflammatory cytokine response in pulmonary
epithelial cells.
Previous studies performed by our group to evaluate the toxicity of 8 different particles col-
lected from the same ITO facility showed SITO to be the most cytotoxic to RAW and BEAS-2B
cells [9]. After baking the same SITO sample, it was still found to cause significantly reduced vi-
ability in both cell lines (Fig 10). Gwinn et al. [11] observed similar findings in RAW cells treat-
ed with ITO particles, with elevated LDH activity beginning at 50 μg/ml, and Lison et al. [10]
observed reduced cell viability in rat lung macrophage cells exposed to SITO using an LDH
assay as well. Therefore, based on the work done by our lab and others, we conclude that ITO
particles are cytotoxic to macrophages, which play a crucial role in taking up foreign particles
and alerting the innate immune system to the presence of foreign particles.
It is important to note the difference in responses observed between unsintered and sintered
ITO. After baking to remove endotoxin activity, the only difference among these samples was
that SITO was subjected to high temperature and pressure (sintering), followed by grinding.
SITO particles are slightly larger in terms of aerodynamic diameter (1.2 ± 0.8 μm SITO vs.
0.7 ± 0.6 μmUITO) and have reduced specific surface compared to UITO (3.0 ± 0.1 m2/g
SITO vs. 4.4 ± 0.2 m2/g UITO). Therefore, the process of sintering creates some yet to be un-
derstood particle change(s) that causes cytotoxicity. This is evident based on the fact that
baked SITO impaired phagocytosis, induced IL-1β release, and reduced viability in RAWmac-
rophages, whereas UITO did not cause these changes.
The present study aimed to evaluate the adverse effects of various ITO production particles
on cultured cells in an attempt to uncover potential mechanisms underlying indium lung dis-
ease. Although the four particle samples were readily taken up by both RAW and BEAS-2B
cells, only those collected from post-sintering processes impaired phagocytic function and in-
duced cytokine production. Overall, it appears that SITO may be the most hazardous to work-
ers in this ITO production facility. This is partially due to the presence of endotoxin, which
played a role in causing a robust inflammatory response in macrophages, and partially due to
the sintered particle itself, which was cytotoxic to both cell lines and pro-inflammatory in
BEAS-2B cells. Although SITO is the only ITO production particle in the current study ex-
pected to be contaminated with endotoxin in a real-life scenario, VD also demonstrated the po-
tential to induce the inflammasome. Thus, risk in this facility is not limited to a single process
or material.
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